CREATES Act Advances in Senate
The Senate Judiciary Committee today voted 16-5 to approve the Creating and Restoring Equal Access to Equivalent Samples Act (S. 974). The AHA-supported bill would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief. More than 45 organizations, including the AHA, last week urged the committee to support the legislation to “end the anticompetitive abuses utilized by some brand-name manufacturers, help restore the balance between innovation and affordability that Congress intended, and achieve the goal of more affordable prescription drugs.” The Congressional Budget Office estimates the legislation will save $3.8 billion over 10 years.
Related News Articles
Perspective
Abraham Lincoln, among those whose legacy we honor with Presidents Day next week, might have put it this way: Thirteen score and three days from now… …
Headline
Capitol Hill was the focus of the second morning of the AHA 2026 Rural Health Care Leadership Conference, taking place through tomorrow in…
Headline
The AHA Feb. 10 released its 2026 Rural Advocacy Agenda, laying out the association's key priorities for Congress, the administration, regulatory agencies and…
Headline
Carmela Coyle, California Hospital Association president and CEO, announced plans Feb. 5 to retire in early 2027, according to the CHA. Coyle has been in…
Headline
The House Feb. 3 voted 217-214 to pass the government funding plan approved by the Senate Jan. 30, ending the four-day partial shutdown. Twenty-one Republicans…
Headline
The Senate has begun consideration of the appropriations package passed by the House Jan. 22, which contains conferenced legislation for the Departments of…